Ubs Group Ag Medtronic PLC Call Options Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

Call Options

28 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$76.84 - $91.03 $3.53 Million - $4.19 Million	46,000 Added 18.28%	297,600 $26.8 Million
Q2 2024 Aug 13, 2024	BUY	$78.71 - $87.02 $5.46 Million - $6.04 Million	69,400 Added 38.09%	251,600 $19.8 Million
Q1 2024 May 13, 2024	BUY	$82.84 - $88.09 $9.68 Million - $10.3 Million	116,800 Added 178.59%	182,200 $15.9 Million
Q4 2023 Feb 09, 2024	BUY	$69.43 - $83.43 $4.51 Million - $5.42 Million	65,000 Added 16250.0%	65,400 $5.39 Million
Q2 2023 Aug 11, 2023	SELL	$79.47 - $91.38 $17.2 Million - $19.8 Million	-216,800 Reduced 99.82%	400 $35,000
Q1 2023 May 12, 2023	SELL	$76.72 - $87.58 $17.7 Million - $20.2 Million	-230,500 Reduced 51.49%	217,200 $17.5 Million
Q4 2022 Feb 08, 2023	SELL	$76.18 - $87.74 $7.72 Million - $8.9 Million	-101,400 Reduced 18.47%	447,700 $34.8 Million
Q3 2022 Nov 10, 2022	BUY	$80.75 - $95.31 $36.7 Million - $43.4 Million	455,000 Added 483.53%	549,100 $44.3 Million
Q2 2022 Aug 10, 2022	BUY	$87.4 - $113.09 $2.88 Million - $3.73 Million	33,000 Added 54.01%	94,100 $8.45 Million
Q1 2022 May 16, 2022	SELL	$100.58 - $112.38 $4.54 Million - $5.07 Million	-45,104 Reduced 42.47%	61,100 $6.78 Million
Q4 2021 Feb 14, 2022	BUY	$99.53 - $127.75 $3.22 Million - $4.13 Million	32,305 Added 43.72%	106,204 $11 Million
Q2 2021 Aug 13, 2021	SELL	$118.19 - $131.5 $65.3 Million - $72.7 Million	-552,500 Reduced 88.2%	73,899 $9.17 Million
Q1 2021 May 12, 2021	BUY	$111.18 - $119.74 $53.8 Million - $57.9 Million	483,599 Added 338.65%	626,399 $74 Million
Q4 2020 Feb 11, 2021	BUY	$100.57 - $117.14 $11.3 Million - $13.2 Million	112,800 Added 376.0%	142,800 $16.7 Million
Q3 2020 Nov 12, 2020	SELL	$90.13 - $108.78 $1.09 Million - $1.32 Million	-12,100 Reduced 28.74%	30,000 $3.12 Million
Q2 2020 Jul 31, 2020	SELL	$84.11 - $103.33 $454,194 - $557,982	-5,400 Reduced 11.37%	42,100 $3.86 Million
Q1 2020 May 01, 2020	SELL	$72.92 - $121.3 $3.31 Million - $5.51 Million	-45,400 Reduced 48.87%	47,500 $4.28 Million
Q4 2019 Feb 14, 2020	SELL	$104.49 - $114.54 $7.95 Million - $8.72 Million	-76,100 Reduced 45.03%	92,900 $10.5 Million
Q3 2019 Nov 14, 2019	SELL	$98.02 - $111.18 $35.4 Million - $40.1 Million	-361,100 Reduced 68.12%	169,000 $18.4 Million
Q2 2019 Aug 14, 2019	BUY	$84.15 - $99.38 $44 Million - $51.9 Million	522,600 Added 6968.0%	530,100 $51.6 Million
Q1 2019 May 14, 2019	SELL	$82.45 - $93.79 $6.41 Million - $7.3 Million	-77,800 Reduced 91.21%	7,500 $683,000
Q4 2018 Feb 14, 2019	BUY	$85.8 - $99.49 $1.3 Million - $1.5 Million	15,100 Added 21.51%	85,300 $7.76 Million
Q3 2018 Nov 14, 2018	SELL	$85.91 - $99.17 $592,779 - $684,273	-6,900 Reduced 8.95%	70,200 $6.91 Million
Q2 2018 Aug 14, 2018	BUY	$77.48 - $87.83 $697,320 - $790,470	9,000 Added 13.22%	77,100 $6.6 Million
Q1 2018 May 15, 2018	SELL	$76.55 - $87.26 $9.19 Million - $10.5 Million	-120,000 Reduced 63.8%	68,100 $5.46 Million
Q4 2017 Feb 14, 2018	BUY	$76.93 - $83.5 $13.6 Million - $14.7 Million	176,600 Added 1535.65%	188,100 $15.2 Million
Q2 2017 Aug 14, 2017	SELL	N/A	-1,100 Reduced 8.73%	11,500 $1.02 Million
Q1 2017 Nov 14, 2017	BUY	N/A	12,600	12,600 $1.02 Million

Others Institutions Holding MDT

# of Institutions

2,288

Shares Held

1.02B

Call Options Held

8.05M

Put Options Held

7.19M

Vanguard Group Inc Valley Forge, PA

123M
Shares

$10.1 Billion
0.2% of portfolio
Black Rock Inc. New York, NY

112M
Shares

$9.12 Billion
0.2% of portfolio
State Street Corp Boston, MA

60.7M
Shares

$4.95 Billion
0.23% of portfolio
Capital Research Global Investors Los Angeles, CA

32.6M
Shares

$2.66 Billion
0.63% of portfolio
Jpmorgan Chase & CO New York, NY

30M
Shares

$2.45 Billion
0.22% of portfolio

View Full List

About Medtronic plc

Ticker MDT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,329,149,952
Market Cap $108B
Description
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...

More about MDT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account